The State of California is considering re-funding its stem cell agency, CIRM, to the tune of more than $5 billion dollars, but the issue has generated surprisingly little media attention. The main coverage has been by David Jensen over at California Stem Cell Report. Prop 14 polling data non-existent in public domain To my knowledge, there are also no poll results in the public domain about how California voters feel about Proposition 14, which is the measure that would give the stem cell agency …Read More
Back at the beginning of the year I surveyed you readers here on The Niche about the future of CIRM and whether California voters would approve more funding for it in November. That funding effort is now on the ballot as Proposition 14. A month earlier late in 2019 in my yearly 20 predictions for the stem cell and regenerative medicine field I had prognosticated that we California voters would narrowly approve more funding for the California Stem Cell Agency. You can see that …Read More
It’s helpful for me to learn about the readers of this blog The Niche in terms of who you are and your backgrounds. Because some people may want to vote more than once on the types of posts they like the most, I’ve allowed re-voting on that poll. Free stuff Those who participate and leave a comment or email me to indicate they did (knoepflerATucdavisDOTedu) will be entered in a random drawing for a bundle of free swag: a stem cell t-shirt and signed …Read More
Take our poll: what will be the fates of the stem cell clinic firms sued by the FDA one year from now in October 2019? To be clear, I am asking for your predictions, not what you hope will be the situation a year from now. U.S. Stem Cell, Inc. (USRM) and California Stem Cell Treatment Center along with its parent stem cell clinic chain Cell Surgical Network were separately but in parallel sued in May by the FDA via the DOJ seeking permanent injunctions …Read More
One of the most common questions about stem cells is economic as patients ask about stem cell treatment cost. How much is the price tag? Empowered with information patients can start thinking like consumers and look out for their own interests more vigorously. I’ve blogged and done polls before about how much patients self-report having paid per treatment, but another important factor needs to be part of this equation: how many stem cell treatments each patient gets. For instance, if a patient reports paying $5,000 …Read More
Heritable CRISPR to be tried in humans sooner or later…or never? Will someone somewhere in the world try to use CRISPR gene editing or related technology to introduce heritable genetic changes into actual human beings in the next decade? I’m not talking about gene editing viable human embryos just for research which is already ongoing, but rather CRISPR’ing human embryos to then use to try to make babies who grow up to be adult humans with a specific genetic change. How likely is this? Take …Read More
Is “snake oil” too harsh a term for some of what is sold at some of the worst stem cell clinics? Is the phrase “stem cell clinics” itself accurate and useful in a broad sense? When we read or write the phrase “stem cell clinics”, most people generally know what we’re talking about, but it is not a very precise use of language, especially these days with so many different clinics out there, and there is a lot of room for error. There are …Read More
Here’s out latest poll: What will Trump admin do about embryonic stem cells?
Will NgAgo strongly challenge CRISPR in coming years? Take our poll and also see the results to find out what others thought. 2020 update: NgoAgo has ending up going nowhere, but 4 years ago we didn’t know that would be it’s fate although some of us were skeptical early on.
Note that this poll is focused on germline, heritable genetic modification. Thus, it does not include somatic cell/gene therapy applications.